Physician

Richard L. Arceneaux, M.D.

According to 2025 Medicare claims, Richard Arceneaux, M.D. (NPI: 1396063996) practices ophthalmology in the Houma-Bayou Cane-Thibodaux, LA market, with the plurality of this provider's patient population coming from Lafourche, LA. This provider's primary affiliated billing organization is ADVANCED EYE INSTITUTE LLC (NPI: 1316436199; TIN: 82-4669835) and primary practice location at 70301-6549.

Arceneaux's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,131 traditional Medicare patients, billed 3,617 HCPCS/CPT codes, and received $333,718 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 5,479 prescription claims across 1,158 beneficiaries totaling $398,557 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 25 records totaling $706. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$211K$422K2015 Medicare payment: $218,432 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $270,422 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $345,427 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $421,548 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $408,358 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $323,776 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $328,490 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $388,384 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $360,498 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $333,718 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156421,973$218,432
20168022,433$270,422
20179853,030$345,427
20181,0553,388$421,548
20199893,275$408,358
20201,0133,183$323,776
20211,0033,331$328,490
20221,1843,907$388,384
20231,0893,564$360,498
20241,1313,617$333,718

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$341K$681K2015 Drug cost: $165,183 (USD; Tot_Drug_Cst)2016 Drug cost: $296,795 (USD; Tot_Drug_Cst)2017 Drug cost: $343,202 (USD; Tot_Drug_Cst)2018 Drug cost: $481,384 (USD; Tot_Drug_Cst)2019 Drug cost: $681,453 (USD; Tot_Drug_Cst)2020 Drug cost: $547,623 (USD; Tot_Drug_Cst)2021 Drug cost: $512,862 (USD; Tot_Drug_Cst)2022 Drug cost: $484,803 (USD; Tot_Drug_Cst)2023 Drug cost: $495,613 (USD; Tot_Drug_Cst)2024 Drug cost: $398,557 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154512,546$165,183
20165853,759$296,795
20176644,228$343,202
20188875,121$481,384
20191,1156,260$681,453
20201,1095,708$547,623
20211,2536,334$512,862
20221,2316,449$484,803
20231,2346,120$495,613
20241,1585,479$398,557

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system630650$73
92012Established patient problem focused exam of visual system325435$50
92136Measurement of corneal curvature and depth of eye258433$26
92134Imaging of retina334357$25
92133Imaging of optic nerve314323$22

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine1367,485$150,794
LumiganBimatoprost1085,158$41,946
Prednisolone AcetatePrednisolone Acetate53920,187$24,470
CyclosporineCyclosporine512,790$22,146
LatanoprostLatanoprost1,660110,172$18,584

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.25$706Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Richard L. Arceneaux, M.D.?

Tedicare shows public-source Medicare data for Richard L. Arceneaux, M.D. (NPI 1396063996), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard L. Arceneaux, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Richard L. Arceneaux, M.D.?

Richard L. Arceneaux, M.D. is linked to ADVANCED EYE INSTITUTE LLC (billing NPI 1316436199) in the available physician profile data.

Does Richard L. Arceneaux, M.D. have Open Payments data?

Richard L. Arceneaux, M.D. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.